HVP
MDT icon

Hudson Value Partners’s Medtronic MDT Stock Holding History

Hudson Value Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,610
Closed -$1.84M – 109
2022
Q1 		$1.84M Sell
16,610
-142
-0.8% -$15K 0.95% 36
2021
Q4 		$1.73M Buy
16,752
+497
+3% +$57.6K 0.84% 36
2021
Q3 		$2.04M Buy
16,255
+945
+6% +$122K 1.12% 31
2021
Q2 		$1.9M Buy
15,310
+595
+4% +$74.7K 1.05% 31
2021
Q1 		$1.74M Buy
14,715
+1,926
+15% +$226K 1.05% 31
2020
Q4 		$1.48M Buy
+12,789
New +$1.41M 0.99% 30

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hudson Value Partners's MDT Position: Q2 2022 in Review

Hudson Value Partners sold out of Medtronic (MDT) in Q2 2022, closing a stake of 16,610 shares — an estimated $1.84M sold.

Hudson Value Partners first reported a position in MDT in Q4 2020 and held it in 6 quarters. The position peaked at $2.04M in Q3 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Hudson Value Partners reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Hudson Value Partners sold 16,610 Medtronic shares in Q2 2022, an estimated $1.84M.
  • Hudson Value Partners first reported a position in Medtronic in Q4 2020 and held it in 6 quarters.
  • Hudson Value Partners's Medtronic position peaked at $2.04M in Q3 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Hudson Value Partners's 13F filing for Q2 2022, filed 29 Jul 2022.